Heterozygous familial hypercholesterolemia (HeFH) is a common genetic disorder predisposing affected individuals to lifelong low-density lipoprotein cholesterol (LDL-C) elevation and coronary heart disease. However, whether HeFH increases the risk of peripheral arterial disease (PAD) and ischemic stroke is undetermined. We examined associations between HeFH and these outcomes in a comprehensive systematic review and meta-analysis. We searched MEDLINE, EMBASE, Global Health, the Cochrane Library, and PubMed (for ahead-of-print publications) for relevant English-language studies. Maximally adjusted risk estimates were pooled under random- and fixed-effects meta-analysis to derive odds ratios (ORs) and 95% confidence intervals (CIs). We included 6 studies representing 183 388 participants. Heterozygnous familial hypercholesterolemia was associated with a higher risk of PAD (OR: 3.59 [95% CI: 1.30-9.89]). This trend was nonsignificantly preserved (OR: 2.96 [95% CI: 0.68-12.88]) in sensitivity analyses of genetically defined HeFH. Genetic HeFH was not associated with increased ischemic stroke risk (OR: 0.76 [95% CI: 0.37-1.58]) although possessing an LDL-C >4.9 mmol/L (190 mg/dL) was (OR: 1.42 [95% CI: 1.06-1.89]). We found clinical and genetic diagnoses of HeFH to be associated with increased PAD risk. Genetically confirmed HeFH may not confer an increased risk of ischemic stroke. Modest associations may exist between LDL-C and ischemic stroke risk in HeFH.
AkioyamenLEGenestJShanSDet al.Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017;7(9):e016461. doi:10.1136/bmjopen-2017-016461
2.
KasteMKoivistoP. Risk of brain infarction in familial hypercholesterolemia. Stroke. 1988;19(9):1097–100. doi:10.1161/01.STR.19.9.1097
3.
BansalBCSoodAKBansalCB. Familial hyperlipidemia in stroke in the young. Stroke. 1986;17(6):1142–45.
4.
GoldsteinJLSchrottHGHazzardWRBiermanELMotulskyAG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52(7):1544–68. doi:10.1172/JCI107332
5.
HutterCMAustinMAHumphriesSE. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am J Epidemiol. 2004;160(5):430–5. doi:10.1093/aje/kwh238
6.
BeheshtiSMadsenCMVarboABennMNordestgaardBG. Relationship of familial hypercholesterolemia and high LDL cholesterol to ischemic stroke: the Copenhagen General Population Study. Circulation. 2018;138(6):578–89. doi:10.1161/CIRCULATIONAHA.118.033470
7.
Pérez de IslaLAlonsoRMataNet al.Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: insights from the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study). Arterioscler Thromb Vasc Biol. 2016;36(9):2004–10. doi:10.1161/ATVBAHA.116.307514
8.
StroupDFBerlinJAMortonSCet al.Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
9.
HendersonRO’KaneMMcGilliganVWattersonS. The genetics and screening of familial hypercholesterolaemia. J Biomed Sci. 2016;23:39. doi:10.1186/s12929-016-0256-1
10.
MantelNHaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–748.
11.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88. doi:10.1016/0197-2456(86)90046-2
12.
GrantRL. Converting an odds ratio to a range of plausible relative risks for better communication of research findings. BMJ. 2014;348:f7450. doi:10.1136/bmj.f7450
13.
RoereckeMRehmJ. Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart. 2014;1(1):e000135. doi:10.1136/openhrt-2014-000135
14.
RoereckeMRehmJ. Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction. 2013;108(9):1562–1578. doi:10.1111/add.12231
15.
Cochrane Handbook for Systematic Reviews of Interventions. 2008. http://handbook.cochrane.org/. Accessed March 15, 2016
PerakAMNingHde FerrantiSDGoodingHCWilkinsJTLloyd-JonesDM. Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype. Circulation. 2016;134(1):9–19. doi:10.1161/CIRCULATIONAHA.116.022335
EmanuelssonFNordestgaardBGBennM. Familial hypercholesterolemia and risk of peripheral arterial disease and chronic kidney disease. J Clin Endocrinol Metab. 2018;103(12):4491–500. doi:10.1210/jc.2018-01058
20.
HumphriesSECooperJASeedMet al.Coronary heart disease mortality in treated familial hypercholesterolaemia: update of the UK Simon Broome FH register. Atherosclerosis. 2018;274:41–46. doi:10.1016/j.atherosclerosis.2018.04.040
21.
FriedmanGDCutterGRDonahueRPet al.Cardia: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105–16. doi:10.1016/0895-4356(88)90080-7
22.
WolfPAAbbottRDKannelWB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham study. Arch Intern Med. 1987;147(9):1561–4.
23.
FriedLPBorhaniNOEnrightPet al.The cardiovascular health study: design and rationale. Ann Epidemiol. 1991;1(3):263–76.
24.
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687–702.
25.
KroonAAAjubiNvan AstenWNStalenhoefAF. The prevalence of peripheral vascular disease in familial hypercholesterolaemia. J Intern Med. 1995;238(5):451–9.
OlinJWSealoveBA. Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc. 2010;85(7):678–92. doi:10.4065/mcp.2010.0133
28.
SigvantBLundinFWahlbergE. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016;51(3):395–403. doi:10.1016/j.ejvs.2015.10.022
29.
MabuchiHHabaTUedaKet al.Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 1977;28(4):417–23. doi:10.1016/0021-9150(77)90068-5
30.
HovlandAMundalLJIglandJet al.Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia. Atherosclerosis. 2017;266:69–73. doi:10.1016/j.atherosclerosis.2017.09.027
31.
Frikke-SchmidtRNordestgaardBGSchnohrPTybjaerg-HansenA. Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke. Eur Heart J. 2004;25(11):943–51.
32.
AkioyamenLEGenestJChuAInibhunuHKoDTTuJV. Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: a systematic review and meta-analysis. J Clin Lipidol. 2019;13(1):15–30. doi:10.1016/j.jacl.2018.10.012
33.
AkioyamenLEGenestJShanSDInibhunuHChuATuJV. Anxiety, depression, and health-related quality of life in heterozygous familial hypercholesterolemia: a systematic review and meta-analysis. J Psychosom Res. 2018;109:32–43. doi: 10.1016/j.jpsychores.2018.03.170
34.
BesselingJKasteleinJJPDefescheJCHuttenBAHovinghGK. Association between familial hypercholesterolemia and prevalence of Type 2 diabetes mellitus. JAMA. 2015;313(10):1029–36. doi:10.1001/jama.2015.1206
35.
Abul-HusnNSManickamKJonesLKet al.Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science. 2016;354(6319). doi:10.1126/science.aaf7000
36.
KheraAVWonHHPelosoGMet al.Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardiol. 2016;67(22):2578–89. doi:10.1016/j.jacc.2016.03.520
37.
HuijgenRHuttenBAKindtIVissersMNKasteleinJJP. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH. Circ Cardiovasc Genet. 2012;5(3):354–359. doi:10.1161/CIRCGENETICS.111.962456
38.
BarkasFElisafMMilionisH. Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis. Atherosclerosis. 2015;243(1):60–64. doi:10.1016/j.atherosclerosis.2015.08.038
39.
BotsMLBaldassarreDSimonAet al.Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?Eur Heart J. 2007;28(4):398–406. doi:10.1093/eurheartj/ehl482
40.
BotsMLHoesAWKoudstaalPJHofmanAGrobbeeDE. Common carotid intima-media thickness and risk of stroke and myocardial infarction. Circulation. 1997;96(5):1432–7. doi:10.1161/01.CIR.96.5.1432
41.
ChamblessLEHeissGFolsomARet al.Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987–1993. Am J Epidemiol. 1997;146(6):483–94. doi:10.1093/oxfordjournals.aje.a009302
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
